Results 131 to 140 of about 9,061 (176)

Timing and Patterns of Relapse-Related Events Following Adjuvant CDK4/6 Inhibitors Combined With Endocrine Therapy in Patients With HR-Positive, HER2-Negative Early Breast Cancer. [PDF]

Cancer Med
Chen H, Wu S, Shan Y, Guo X, Lu W, Chen Y, Zhou Y.   +6 more
europepmc   +1 more source

A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case-control pilot study. [PDF]

Breast
Generali D, Membrino A, Fontana A, Gattazzo F, Strina C, Milani M, Cervoni V, Caltavituro A, Castagnetti A, Del Bianco S, Schettini F.   +10 more
europepmc   +1 more source

Comparative efficacy of CDK4/6 inhibitors palbociclib, ribociclib, and abemaciclib in HR⁺/HER2^- advanced breast cancer. [PDF]

Am J Cancer Res
Hou B, Zhang Y.
europepmc   +1 more source

Liver Resection after Disease Control with Abemaciclib for Solitary Liver Metastasis from Breast Cancer: A Case Report. [PDF]

Surg Case Rep
Kurokawa Y, Terakawa H, Mohri R, Hirata M, Gabata R, Yagi S, Inaki N.   +6 more
europepmc   +1 more source

Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression on palbociclib-based therapy. [PDF]

Front Med (Lausanne)
Peng X, Chang W.
europepmc   +1 more source

Post-CDK4/6 inhibitor therapy in HR+/HER2- advanced breast cancer: expanding options and persisting uncertainties. [PDF]

Explor Target Antitumor Ther
Hollinger AM, Bill R.
europepmc   +1 more source

Real-world treatment durations, subsequent treatments, and switching of CDK4/6 inhibitors among patients with HR+/HER2- metastatic breast cancer. [PDF]

Oncologist
Brufsky A, Brufsky A, Layman RM, Liu X, Li B, McRoy L, Cohen A, Estevez M, Cottu P, Thill M, Curigliano G, Rugo HS.   +11 more
europepmc   +1 more source

A cyclin D1-CDK4/6-E2F dependency represents an acquired vulnerability in cisplatin-resistant bladder cancer. [PDF]

Biol Direct
Hsieh TH, Kuo HP, Pan CH, Lin YC, Lin BJ, Chen MC, Chen CH.   +6 more
europepmc   +1 more source

Role of sentinel lymph node biopsy in patients with early breast cancer undergoing mastectomy. [PDF]

BJS Open
Heidinger M, Montagna G, Halbeisen FS, Eberhardt AL, Maggi N, Frevert ML, Dollt K, Kiblawi R, Loesch JM, Winkler J, Schwab FD, Kurzeder C, Zwimpfer TA, Weber WP.   +13 more
europepmc   +1 more source

The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patients. [PDF]

Ther Adv Drug Saf
Crucitta S, Cinacchi P, Bargagna I, Biondani P, Giontella E, Palleschi M, Omarini C, Belluzzi L, Angelini L, Meattini I, Visani L, Stucci S, Porta C, Fontana A, De Giorgi U, Fogli S, Danesi R, Del Re M.   +17 more
europepmc   +1 more source